Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, HIV Research and Treatment, and SARS-CoV-2 and COVID-19 Research.
Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome
Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic
Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
Highly Sensitive and Selective Direct Detection of Zika Virus Particles in Human Bodily Fluids for Accurate Early Diagnosis of Infection
Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques
Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus–Specific CD8+ T Cells
<i>Mamu-B*17</i> <sup>+</sup> Rhesus Macaques Vaccinated with <i>env</i> , <i>vif</i> , and <i>nef</i> Manifest Early Control of SIVmac239 Replication
Genomic epidemiology reveals multiple introductions of Zika virus into the United States
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network
Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques
Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus
Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques
Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys
Analysis of Simian Immunodeficiency Virus-specific CD8<sup>+</sup> T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining